Please assess the completion status of the following clinical trial:

Trial Title: Maintenance Dosing of Vitamin D in Crohn's Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: EARLY_PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis of Crohn's disease~2. In clinical remission as determined by the Harvey Bradshaw Index (CD) ≤4~3. 25(OH)D level \<30 ng/ml within three months of study enrollment~4. Prior 25(OH)D level \<30 ng/ml currently on repletion therapy~5. Provided written informed consent~6. 18 years of age or older~7. All maintenance therapies required to be on stable doses for 3 months.~Exclusion Criteria:~1. Unwilling to provide consent or lack capacity~2. Clinical disease activity (Harvey Bradshaw index \>4)~3. Current pregnancy or attempting to conceive~4. Hypercalcemia (must have calcium level within 6 months of enrollment)~5. Known coexisting hyperparathyroidism~6. BMI \>30 kg/m²~7. History of kidney stones~8. Subjects \<18 years of age - pediatric population with different recommended dosing than adults~9. Non-english speakers~10. Has an ileo-anal pouch or ileostomy~11. C-reactive protein greater than 2x the upper limit of normal~12. Lactose intolerant~13. Short gut syndrome~14. Renal insufficiency (CrCl \<60 ml/min)~15. Concomitant therapy with thiazide diuretics, barbiturates, digitalis or supplemental products containing vitamin D~16. Vitamin D levels \<30ng/ml at completion of lead in

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Vitamin D 1000 IU D3 daily (Type: ACTIVE_COMPARATOR): None
- Vitamin D 5000 IU D3 daily (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).